Repaglinide

In the US, Repaglinide (repaglinide systemic) is a member of the drug class meglitinides and is used to treat Diabetes, Type 2.

US matches:

• Repaglinide


• Repaglinide/Metformin


• Repaglinide and metformin


• Repaglinide/Metformin Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BX02

CAS registry number (Chemical Abstracts Service)

0135062-02-1

Chemical Formula

C27-H36-N2-O4

Molecular Weight

452

Therapeutic Category

Oral antidiabetic agent, meglitinide (glinide)

Chemical Name

(+)-2-Ethoxy-α-[[(S)-α-isobutyl-o-piperidinobenzyl]carbamoyl]-p-toluic acid

Foreign Names

• Repaglinidum (Latin)
• Repaglinid (German)
• Répaglinide (French)
• Repaglinida (Spanish)

Generic Names

• Repaglinide (OS: BAN, USAN)
• Répaglinide (OS: DCF)
• AG-EE 623 ZW (IS)
• Repaglinide (PH: BP 2010, Ph. Eur. 6, USP 32)
• Repaglinidum (PH: Ph. Eur. 6)

Brand Names

• Dexanorm
  Dexa Medica, Indonesia



• Dianorm Rephco
  Rephco, Bangladesh



• Diarepa
  Techno, Bangladesh



• Enyglid
  TAD, Germany



• Glimet
  Drug International, Bangladesh



• Gluconorm
  Novo Nordisk, Canada



• Glukenil
  Lazar, Argentina



• Hipover
  Biopharm, Chile; Farmindustria, Peru



• Nomopil
  Incepta, Bangladesh



• Novade
  Eczacibasi, Turkey



• Novo Norm
  Novo Nordisk, Oman; Novo Nordisk, Romania



• NovoNorm
  Novo Nordisk, Argentina; Novo Nordisk, Austria; Novo Nordisk, Australia; Novo Nordisk, Bosnia & Herzegowina; Novo Nordisk, Belgium; Novo Nordisk, Bahrain; Novo Nordisk, Switzerland; Novo Nordisk, Chile; Novo Nordisk, China; Novo Nordisk, Cyprus; Novo Nordisk, Czech Republic; Novo Nordisk, Germany; Novo Nordisk, Denmark; Novo Nordisk, Egypt; Novo Nordisk, Spain; Novo Nordisk, Finland; Novo Nordisk, France; Novo Nordisk, Greece; Novo Nordisk, Hong Kong; Novo Nordisk, Croatia (Hrvatska); Novo Nordisk, Hungary; Novo Nordisk, Ireland; Novo Nordisk, Israel; Novo Nordisk, Iraq; Novo Nordisk, Iran; Novo Nordisk, Iceland; Novo Nordisk, Italy; Novo Nordisk, Jordan; Novo Nordisk, Kuwait; Novo Nordisk, Lebanon; Novo Nordisk, Luxembourg; Novo Nordisk, Myanmar; Novo Nordisk, Mexico; Novo Nordisk, Malaysia; Novo Nordisk, Netherlands; Novo Nordisk, Norway; Novo Nordisk, Peru; Novo Nordisk, Poland; Novo Nordisk, Qatar; Novo Nordisk, Serbia; Novo Nordisk, Russian Federation; Novo Nordisk, Saudi Arabia; Novo Nordisk, Sudan; Novo Nordisk, Sweden; Novo Nordisk, Singapore; Novo Nordisk, Slovenia; Novo Nordisk, Slovakia; Novo Nordisk, Syria; Novo Nordisk, Tunisia; Novo Nordisk, Turkey; Novo Nordisk, Taiwan; Novo Nordisk, Yemen; Novo Nordisk, South Africa



• Prandil
  Unimed & Unihealth, Bangladesh



• Prandin
  Daiichi Sankyo, United Kingdom; Menarini, Spain; Novo Nordisk, Luxembourg; Novo Nordisk, United States; Sanfer, Mexico



• Premil
  Beximco, Bangladesh; Beximco, Myanmar



• Rapilin
  Sun, India; Sun, Myanmar



• Regan
  Stancare, India



• Reglin
  General Pharma, Bangladesh



• Reodon
  Pliva, Croatia (Hrvatska)



• Repaglid
  Alco, Bangladesh



• Repaglind Stada
  Stada, Germany



• Repaglinid AbZ
  AbZ, Germany



• Repaglinid AL
  Aliud, Germany



• Repaglinid Hexal
  Hexal, Germany



• Repaglinid-CT
  CT Arzneimittel, Germany



• Repaglinid-ratiopharm
  Ratiopharm, Germany



• Sestrine
  Beta, Argentina



• Singlin
  Renata, Bangladesh



• Supernide
  Yu Sheng, Taiwan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.